,13,20,97 From clinical practice, multiple risk factors of INH hepatotoxicity have been identified including aging, co-treatment with drugs as CYP inducers, and individuals with pre-existing liver diseases (Fig. 2).7 This evidence concerns the gene PPIG and liver disorder.